• +91 882 525 4416
  • bd@essentialmarketinsights.com
  • Pune, MH, India

September 2020 | PDF | 190 Pages | Oligonucleotide | Pharmaceuticals | Market Research

Global Oligonucleotide Synthesis Market Analysis (2015-19), By Product (Synthesized Oligos, Predesigned Oligos, Custom Oligos, Others), By Application (Therapeutic Application, Diagnostic Application, and Research Application), By End User (Hospital, Diagnostic Laboratories, Academic Research Institutes, and Pharmaceutical & Biotechnology Companies) and Forecasting (2020-2025)

Market Outlook, Growth Perspectives, Regional Markets, Value Chain Analysis, Competitive Analysis, Company Profiles

Project Overview



Oligonucleotide synthesis is the chemical synthesis of nucleic acids with a specified chemical sequence in various sizes. The method is used for several applications under the life science research and medicine research. Earlier, the companies followed the typical traditional way of oligonucleotide synthesis, carried out manually on solid or in the liquid phase supported by glass columns, kitted with porous filters. The traditional method was not much successful as it failed to obtain the desired outcome. Currently, owing to the growing advancements in the modern solid phase-based synthesis technologies, oligonucleotide synthesis is carried out automatically via computer-controlled instruments, which is commercially available in column and multi-well formats. The oligonucleotide synthesis allows rapid and low-cost access to custom-made oligonucleotides of the desired sequence that makes it exceptionally useful in the current laboratory practices.


Growth Factors


Rising Government Initiatives & and R&D Expenditure in Pharmaceutical and Biotechnology Companies

Custom DNA Oligos Synthesis Services : Several market players are focusing on providing synthesis services, which are based on desirable specifications with responsive quality control, and quick turnaround for use in a variety of applications, including gene detection, cloning, PCR, and sequencing.

Rise in Venture Capital Investments : Over the years, the exponential growth in the field of genomics and advanced technologies in biotechnology have created immense potential for synthetic biology to transform medicine and life science research. Recently, several start-ups are achieving greater traction with growing interest from investors and venture capitalists. For instance, a SAN FRANCISCO-based company, Twist Bioscience Corporation, which is engaged in accelerating science and innovation through rapid, and high-quality DNA synthesis, has raised an additional $27 million in venture financing, in March 2017. Moreover, in March 2020, a UK-based Evonetix has announced its Series B funding, in which the company has raised $30 million US$ (£23 million GBP) that was headed by Foresite Capital.

Increasing Use of Synthesized Oligos in Molecular Diagnostics and Clinical Applications: The oligonucleotides can be used in IVD applications and molecular diagnostics testing to detect the risks, monitor diseases, and determine the best appropriate therapies for each individual patient.


Emerging Spots


Geography: Asia Pacific is a very lucrative market for oligonucleotide synthesis since it holds almost XX of the overall market with a growth rate of XX% PA. Affordability, increase in chronic diseases, push for growing research-oriented programs, growing applications in genetics & therapeutics, etc. are some of the reasons why this region is seeing huge increase in the oligonucleotide synthesis market.


  • Updates

Many companies in APAC are exploring an increase in approvals and exports to the EU and the US. Some recent updates include the following:

• Twist Bioscience has launched its long oligonucleotides, or oligos, product line, in July 2019. It is the longest commercial oligo in length, at up to 300 bases, or nucleotides.

• LGC Genomics Ltd. has launched two new products to support oligonucleotide synthesis, namely triplex and ethyl phosphoramidites.




Companies covered in this section include Danaher, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., GENERAL ELECTRIC COMPANY, GeneDesign Inc., Kaneka Eurogentec S.A. and, LGC Biosearch Technologies



Oligonucleotide Synthesis Market can be segmented into the following:


By Products

• Synthesized Oligos

⋅ Oligonucleotide-based Drugs

⋅ Primers

⋅ Probes

⋅ Intermediate-scale Synthesized Oligos

⋅ Large-scale Synthesized Oligos

⋅ Linkers & Adaptors

⋅ Others

• Predesigned Oligos

• Custom Oligos

• Others


By Application

         • Therapeutic Applications

⋅ DNA & Antisense Oligonucleotide-based Therapies

⋅ RNAi Oligonucleotide-based Therapies

⋅ CpG Oligonucleotide-based Therapies

• Diagnostic Applications

• Research Applications


By End User

• Hospitals

• Diagnostic Laboratories

• Academic Research Institutes

• Pharmaceutical & Biotechnology Companies


By Region

North America

• US

• Canada


• UK

• Germany

• France

• Spain

• Italy

• Russia

• Others


• India

• China

• S.Korea

• Japan

• Australia

• Others


• Mexico

• Brazil

• Argentina

• Chile

• Peru

• Others

Africa and Middle East

• Israel

• Turkey

• Egypt

• Saudi Arabia

• South Africa

• Others

To get a copy of Table of Contents (ToC), Report Blue Print or Sample Copy please Click HERE

To get a copy of List of Deliverables please share your requirements HERE

We offer customized reports as per our customers requirements. This covers a 360 degree deliverable scope study such as:

  • You may need some additional insights in MARKET RESEARCH report as per your decision making team. Please let us know your requirements.
  • You may require a SOURCING INTELLIGENCE report for this topic as per requirement for your sourcing/procurement teams. You may let us know your requirements and we will prepare a feasibility study for your perusal.
  • You may require a hybrid report consisting of Market Research Data and Sourcing Intelligence inputs in one report. Please let us know your requirement and we will share the list of deliverables for this Market Intelligence.
  • You may require an Extensive and Potential List of Suppliers or Potential List of Customers Or List of other Stakeholders. Please feel to let us know and we will share the scope study.

This section covers very brief quick reports as a scale down version of original Market Research report. You may be any of the following:

  • You may require market data in a quick interval of time, and you don’t have further need.
  • You are a research scholar and you need market research in brief for some project
  • Due to budget constraints you may need market research report in brief

Please don’t worry and write to us HERE

For any other discussion such as related to various reports, future business requirements, feasibility discussion, etc. Or for talk to our sales team executive please feel free to reach out to us HERE

Related Projects

Global Oncology/Cancer Biosimilars Market

North America Biosimilars Market

Europe Biosimilars Market

Global Biosimilars Insulin Market

contact us

We are here to help you




+91 882 525 4416